Mukhtar Nizar A, Toy Brian C, Burman Blaire E, Yu Albert, Chen Alice Hm, Berman Peter, Nguyen Tung, Chan Daniel, Hammer Hali, McCulloch Charles E, Khalili Mandana
Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
J Gen Intern Med. 2015 Jan;30(1):68-74. doi: 10.1007/s11606-014-3057-9. Epub 2014 Oct 17.
Hepatitis B (HBV) represents a significant health disparity among medically underserved Asian and Hawaiian/Pacific Islander (API) populations. Studies evaluating adherence to HBV screening and vaccination guidelines in this population are limited.
The purpose of this study was to evaluate HBV screening and vaccination practices using both provider self-report and patient records.
Medical records for 20,574 API adults were reviewed retrospectively and primary care providers were surveyed to evaluate rates and adherence to HBV screening and vaccination guidelines.
The study included primary care providers and their adult API patients in the San Francisco safety-net healthcare system.
Patient, practice, and provider factors, as well as HBV screening and vaccination practices, were assessed using provider survey constructs and patient laboratory and clinical data. Generalized linear mixed models and multivariate logistic regression analyses were used to identify factors associated with recommended HBV screening and vaccination.
The mean age of patients was 52 years, and 63.4 % of patients were female. Only 61.5 % underwent HBV testing, and 47.4 % of HBV-susceptible patients were vaccinated. Of 148 (44.8 %) responding providers, most were knowledgeable and had a favorable attitude towards screening, but 43.2 % were unfamiliar with HBV guidelines. HBV screening was positively associated with favorable provider attitude score (OR per unit 1.80, 95 % CI 1.18-2.74) and negatively associated with female patient sex (OR 0.82, 95 % CI 0.73-0.92), a higher number of clinic patients per week (OR per 20 patients 0.46, 95 % CI 0.28-0.76), and provider barrier score (OR per unit 0.45, 95 % CI 0.24-0.87). HBV vaccination was negatively associated with provider barrier score (OR per unit 0.48, 95 % CI 0.25-0.91).
Rates of HBV screening and vaccination of API patients in this safety-net system are suboptimal, and provider factors play a significant role. Efforts to cultivate positive attitudes among providers and expand healthcare system resources to reduce provider barriers to HBV care are warranted.
乙型肝炎(HBV)在医疗服务不足的亚洲及夏威夷/太平洋岛民(API)人群中是一个显著的健康差异问题。评估该人群对HBV筛查和疫苗接种指南依从性的研究有限。
本研究的目的是通过提供者自我报告和患者记录来评估HBV筛查和疫苗接种情况。
对20574名API成年患者的病历进行回顾性审查,并对初级保健提供者进行调查,以评估HBV筛查和疫苗接种指南的执行率及依从性。
该研究纳入了旧金山安全网医疗系统中的初级保健提供者及其成年API患者。
使用提供者调查结构以及患者实验室和临床数据,评估患者、医疗机构和提供者因素,以及HBV筛查和疫苗接种情况。采用广义线性混合模型和多因素逻辑回归分析来确定与推荐的HBV筛查和疫苗接种相关的因素。
患者的平均年龄为52岁,63.4%为女性。仅61.5%的患者接受了HBV检测,47.4%的HBV易感患者接种了疫苗。在148名(44.8%)做出回应的提供者中,大多数知识渊博且对筛查持积极态度,但43.2%不熟悉HBV指南。HBV筛查与提供者积极态度得分呈正相关(每单位比值比1.80,95%可信区间1.18 - 2.74),与女性患者性别呈负相关(比值比0.82,95%可信区间0.73 - 0.92),与每周诊所患者数量较多呈负相关(每增加20名患者比值比0.46,95%可信区间0.28 - 0.76),与提供者障碍得分呈负相关(每单位比值比0.45,95%可信区间0.24 - 0.87)。HBV疫苗接种与提供者障碍得分呈负相关(每单位比值比0.48,95%可信区间0.25 - 0.91)。
该安全网系统中API患者的HBV筛查和疫苗接种率未达最佳水平,提供者因素起重要作用。有必要努力培养提供者的积极态度,并扩大医疗系统资源以减少提供者在HBV治疗方面的障碍。